FDA Issues Revised Draft Guidance on Off-Label Communications to Health Care Providers – Expanded Scope, Yet Limitations Remain | Dechert LLP

The FDA issued Revised Draft Guidance addressing communications by drug and device manufacturers about “off-label” uses of approved products. The Revised Draft Guidance...

Related Keywords

,Categories Of Communications ,Communications Should Not Use Persuasive Marketing Techniques ,Device Manufacturer Communications With Payors ,Drug Administration ,Communications Should Be Clinically Relevant ,Revised Draft Guidance ,Medical Publications ,Unapproved New Uses ,From Firms ,Unapproved Uses ,Cleared Medical Products ,Recommended Practices ,Federal Food ,Cosmetic Act ,Draft Guidance ,Differences Between ,Should Not Use ,World Data ,First Amendment ,Use Final Rule ,Formulary Committees ,Similar Entities ,